{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:46Z","timestamp":1786119046504,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,16]]},"DOI":"10.1097\/wnr.0b013e3282fb7898","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T19:49:07Z","timestamp":1236109747000},"page":"657-660","source":"Crossref","is-referenced-by-count":8,"title":["The novel cyclooxygenase-2 inhibitor GW637185X protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity"],"prefix":"10.1097","volume":"19","author":[{"given":"Jose A.","family":"Aguirre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Andbjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Medhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi F.","family":"Agnati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Fuxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210201","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"R2-11-20210201","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/mds.870120604","article-title":"The role of the immune system in neurodegenerative disorders","volume":"12","author":"McGeer","year":"1997","journal-title":"Mov Disord"},{"key":"R3-11-20210201","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson's disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R4-11-20210201","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R5-11-20210201","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"R6-11-20210201","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.2003.tb07482.x","article-title":"COX-2 and neurodegeneration in Parkinson's disease","volume":"991","author":"Teismann","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R7-11-20210201","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R8-11-20210201","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0304-3940(02)00704-8","article-title":"Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra","volume":"329","author":"Feng","year":"2002","journal-title":"Neurosci Lett"},{"key":"R9-11-20210201","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/00001756-200310270-00009","article-title":"COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice","volume":"14","author":"Feng","year":"2003","journal-title":"Neuroreport"},{"key":"R10-11-20210201","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1046\/j.1471-4159.1995.64041645.x","article-title":"Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease","volume":"64","author":"Mattammal","year":"1995","journal-title":"J Neurochem"},{"key":"R11-11-20210201","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-11-20210201","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","article-title":"Pathogenic role of glial cells in Parkinson's disease","volume":"18","author":"Teismann","year":"2003","journal-title":"Mov Disord"},{"key":"R13-11-20210201","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nbd.2003.12.014","article-title":"Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase","volume":"15","author":"Klivenyi","year":"2004","journal-title":"Neurobiol Dis"},{"key":"R14-11-20210201","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(02)00353-4","article-title":"Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury","volume":"104","author":"Kyrkanides","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"R15-11-20210201","first-page":"973","article-title":"Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms","volume":"35","author":"Molina-Holgado","year":"2002","journal-title":"Rev Neurol"},{"key":"R16-11-20210201","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/hs1001.096057","article-title":"Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity","volume":"32","author":"Araki","year":"2001","journal-title":"Stroke"},{"key":"R17-11-20210201","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2001.tb03612.x","article-title":"Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors","volume":"939","author":"Brambilla","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R18-11-20210201","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jnr.20559","article-title":"Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat","volume":"81","author":"Wang","year":"2005","journal-title":"J Neurosci Res"},{"key":"R19-11-20210201","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.wco.0000169752.54191.97","article-title":"Role of inflammation in neurodegenerative diseases","volume":"18","author":"Minghetti","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"R21-11-20210201","article-title":"A novel inhibitor of cyclooxygenase 2 fully protects nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals against acute MPTP toxicity in mice. 7th IBRO World Congress of Neuroscience. Melbourne, Australia; 2007.","author":"Aguirre","year":"337","journal-title":"p"},{"key":"R22-11-20210201","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2004.11.040","article-title":"Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP","volume":"1033","author":"Aguirre","year":"2005","journal-title":"Brain Res"},{"key":"R23-11-20210201","article-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"1997"},{"key":"R24-11-20210201","first-page":"5","article-title":"Computer-assisted morphometry and microdensitometry of transmitter-identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects","volume":"532","author":"Agnati","year":"1984","journal-title":"Acta Physiol Scand Suppl"},{"key":"R25-11-20210201","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0197-0186(91)90165-A","article-title":"Regional increases in ornithine decarboxylase mRNA levels in the rat brain after partial mesodiencephalic hemitransection as revealed by in situ hybridization histochemistry","volume":"18","author":"Zoli","year":"1991","journal-title":"Neurochem Int"}],"container-title":["NeuroReport"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001756-200804160-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:38:36Z","timestamp":1786037916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001756-200804160-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,16]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wnr.0b013e3282fb7898","relation":{},"ISSN":["0959-4965"],"issn-type":[{"value":"0959-4965","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4,16]]}}}